S
Cameron Durrant
WW VP, Global Strategic Marketing, Virology, J&J
YOU DIDN'T KNOW: While working as a physician, he opened a men's clothing company
Declaring a weakness is actually a strength." "You acquire more power by giving it up." Paradoxes like these are Cameron Durrant's stock-in-trade—visionary thinking about new leadership in pharma. "Tradition can be torn up," he says. "We can reinvent how we deliver value."
Cameron Durrant
Durrant's background is anything but traditional. "I grew up in pretty deprived circumstances," he recalls. "The school I went to—no one had gone to medical school before. 'It's just not possible,' I was told at 13." He took this as a challenge—and ultimately become an MD. "I see adversity as an opportunity to be resilient."
This preparation is perfect training to lead an industry facing unprecedented adversity. Currently running J&J's global strategic marketing for its virology portfolio (including HIV, hep C, and TB), Durrant is keen on creating "new healthcare partnerships, philanthropic models, ways of bringing information to customers."
He added business brains to his own portfolio by starting a medical devices company and heading strategic development at Pharmacia, among other jobs. This range has given Durrant a unique view on the industry's pitfalls and potentials. The only constant, he says, is change. The way forward is "servant leadership, greater transparency, [plus everything from] safe environments for employees to exquisite levels of service solutions for customers."
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.